
The Associate Director, Network Supply Planning is a senior team member within the Global Supply
Planning Team in Astra Zeneca Alexion Rare Disease Business Unit (RDBU), responsible for
supporting the end-to-end tactical supply planning agenda across the network over a 0–3-year
horizon. The role supports integrated planning and supply oversight across all supply chain nodes,
contributing to strong performance in service, inventory, and cost while supporting broader business
and portfolio objectives.
This roles supports alignment across demand, supply, inventory, and operational priorities to enable
informed decision-making and effective management of trade-offs and supply risks for the
network. The Associate Director works across cross-functional teams to support robust plan
validation, proactive issue resolution, and timely escalation of critical risks through the appropriate
governance channels.
The role contributes to strengthening network supply planning capabilities and governance by
supporting structured risk management, improving planning discipline, and advancing mitigation plans
that support business continuity, launch readiness, supply reliability, and network resilience. The
position also supports strategic decision-making by highlighting emerging risks, scenario
impacts, and operational considerations that may influence portfolio execution and mid to long-term
supply performance.
The ideal candidate should possess significant experience in global supply planning and
network operations, supply chain strategy, and cross-functional collaboration, particularly in complex,
matrixed, and regulated environments. They should demonstrate strong capability in supply chain
operations, with the ability to collaborate across functions, make sound operational decisions,
manage risk, support continuous improvement, and translate strategic priorities into effective
execution.
contributing expertise and ensuring supply network planning activities support business priorities,
patient needs, regulatory requirements, and market-specific considerations.
development, encouraging accountability, and fostering collaboration and continuous
improvement across the global network supply planning team.
supply plans aligned across the global network to deliver reliable product supply, appropriate
inventory levels, and effective capacity utilisation.
partners, and distribution networks.
improve consistency, transparency, decision-making quality, and compliance across the network.
planning, identifying vulnerabilities early and supporting the development and execution of
proactive plans to minimise impact to patients and the business.
situations while balancing patient supply, financial impact, operational feasibility, and compliance
strengthening integration between demand, supply, capacity, inventory, and business priorities
across the network. Assess trade-offs, support resolution of imbalances, and enable timely
decisions related to supply constraints, prioritisation, allocation, and network performance.
delivery, inventory value, months on hand, plan attainment, and supply reliability, using insights to
drive accountability and performance improvement.
and performance trends to guide actions and support effective issue resolution.
business reviews, and resource planning, ensuring operational plans are aligned to financial
commitments.
quality, finance, internal / external manufacturing, product management, technical operations, and
logistics to ensure aligned planning and execution.
collaboration, alignment on priorities & rapid resolution of supply issues.
opportunities to simplify workflows, reduce inefficiencies, improve responsiveness, and strengthen
planning accuracy.
planning, network operations, or related disciplines within a complex, global, and highly
regulated environment, typically gained over 10+ years.
planning, or end-to-end supply chain management, with a strong track record of
delivering results through expertise, collaboration, and influence across global and matrixed
organisations.
supply, distribution, and market delivery, with the ability to manage trade-offs across service,
inventory, capacity, cost, and compliance.
launch readiness, or product lifecycle planning is strongly preferred.
tools, including experience contributing senior expertise to complex risk assessments
involving multiple stakeholders and functions.
success in working cross-functionally across supply chain manufacturing, quality,
regulatory, finance, commercial, and external partners.
complex data, assess network and supply risks, and translate insights into practical mitigation
and execution plans.
judgment to balance short-term operational needs and long-term business objectives.
engaging senior leaders, contributing to governance discussions, and supporting crossfunctional decision-making forums.
improve supply chain effectiveness, enhance visibility, and drive business performance.
supply planning performance, network health, service outcomes, inventory management, and
risk mitigation effectiveness.
ways of working to enhance consistency, transparency, decision-making, and organisational
resilience.
demonstrated commitment to compliance, inspection readiness, record management, and
continuous improvement of quality-relevant processes within area of responsibility.
including platforms such as Smartsheet or similar systems, is desirable.
related discipline is required.
05-Oct-2026
18-Oct-2026
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy